|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-6-2
|
|
pubmed:abstractText |
AIDS-related lymphoma contributes to significant morbidity and mortality among human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART). We assessed the predictive role of cumulative HIV viremia and other risk factors in the development of AIDS-related non-Hodgkin lymphoma.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
200
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
79-87
|
|
pubmed:dateRevised |
2009-11-12
|
|
pubmed:meshHeading |
pubmed-meshheading:19476437-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19476437-CD4 Lymphocyte Count,
pubmed-meshheading:19476437-Cohort Studies,
pubmed-meshheading:19476437-Female,
pubmed-meshheading:19476437-Germany,
pubmed-meshheading:19476437-HIV Infections,
pubmed-meshheading:19476437-Humans,
pubmed-meshheading:19476437-Lymphoma, AIDS-Related,
pubmed-meshheading:19476437-Male,
pubmed-meshheading:19476437-Proportional Hazards Models,
pubmed-meshheading:19476437-Risk Factors,
pubmed-meshheading:19476437-Survival Analysis,
pubmed-meshheading:19476437-Viral Load,
pubmed-meshheading:19476437-Viremia
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
|
|
pubmed:affiliation |
Infectious Diseases Unit, Department of Medicine, University Medical Center Hamburg-Eppendorf, Germany. a.zoufaly@uke.uni-hamburg.de
|
|
pubmed:publicationType |
Journal Article
|
